The global Companion Animal Pharmaceuticals Market in terms of revenue was estimated to be worth $14.4 billion in 2022 and is poised to reach $19.6 billion by 2027, growing at a CAGR of 6.3% from 2022 to 2027. The growth in this market is majorly driven by the growth in adoption rate of companion animals, rising zoonotic diseases in companion animals, rising demand for pet insurance, and...